|

UnitedHealth stock gains alongside other insurers on Trump’s Dr. Oz nomination

  • UnitedHealth stock gains on Dr. Oz being named to Trump administration.
  • Trump pushed Mehmet Oz's nomination to be head of Centers for Medicare & Medicaid Services.
  • Oz is considered likely to push more Medicare Advantage plans, which benefit private-sector insurers like UNH.
  • UNH stock is testing the $600 resistance level on Wednesday.

UnitedHealth Group (UNH) stock surged more than 3% on Wednesday as investors bid up most US health insurers after President-elect Donald Trump named Dr. Oz to manage the government’s healthcare insurance unit for the elderly and indigent. 

The market is bracing for Nvidia (NVDA) earnings that arrive after the close on Wednesday, so the Dow Jones Industrial Average (DJIA), which contains both UnitedHealth and Nvidia, has slumped slightly. Only the S&P 500 has made gains among the major equity indices on Wednesday, and the NASDAQ is faring the worst, down 0.7%.

UnitedHealth stock news

Dr. Mehmet Oz, better known as Dr. Oz on television, has been a well-known face of medicine for years. Through his appearances on the Oprah Winfrey Show and elsewhere, Dr. Oz became a common personality for those seeking medical advice before then running and losing as the Republican Senate nominee for Pennsylvania in 2022.

Trained as a cardiothoracic surgeon, Oz has been named by the incoming Trump administration to head the Centers for Medicare & Medicaid Services (CMMS). This part of the government manages trillions of dollars that provide healthcare for retirees (Medicare) and those without means (Medicaid).

The basic gist here is that Dr. Oz has made positive statements in regard to Medicare Advantage plans. These plans give private insurers the ability to manage government Medicare plans for a profit.

Besides UnitedHealth, other insurers like CVS Health’s (CVS) Aetna unit, Elevance Health (ELV) and Humana (HUM) all saw their share prices climb on Wednesday.

JPMorgan pointed to postive statements that Dr. Oz made during his Senate run in 2022.

"We can expand Medicare Advantage plans," Oz said back on the campaign trail two years ago. "These plans are popular among seniors, consistently provide quality care, and have a needed incentive to keep costs low."

UnitedHealth stock chart

UNH stock is having trouble attacking the $600 level. Above there, resistance at $608 looms.

UNH daily stock chart

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

Clay Webster

Clay Webster

FXStreet

Clay Webster grew up in the US outside Buffalo, New York and Lancaster, Pennsylvania. He began investing after college following the 2008 financial crisis.

More from Clay Webster
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD bounces toward 1.1750 as US Dollar loses strength

EUR/USD returned to the 1.1750 price zone in the American session on Friday, despite falling Wall Street, which indicates risk aversion. Trading conditions remain thin following the New Year holiday and ahead of the weekend, with the focus shifting to US employment and European data scheduled for next week.

GBP/USD nears 1.3500, holds within familiar levels

After testing 1.3400 on the last day of 2025, GBP/USD managed to stage a rebound. Nevertheless, the pair finds it difficult to gather momentum and trades with modest intraday gains at around 1.3490 as market participants remain in holiday mood.

Gold trims intraday gains, approaches $4,300

Gold retreated sharply from the $4,400  area and trades flat for the day in the $4,320 price zone. Choppy trading conditions exacerbated the intraday decline, although XAU/USD bearish case is out of the picture, considering growing expectations for a dovish Fed and persistent geopolitical tensions.

Cardano gains early New Year momentum, bulls target falling wedge breakout

Cardano kicks off the New Year on a positive note and is extending gains, trading above $0.36 at the time of writing on Friday. Improving on-chain and derivatives data point to growing bullish interest, while the technical outlook keeps an upside breakout in focus.

Economic outlook 2026-2027 in advanced countries: Solidity test

After a year marked by global economic resilience and ending on a note of optimism, 2026 looks promising and could be a year of solid economic performance. In our baseline scenario, we expect most of the supportive factors at work in 2025 to continue to play a role in 2026.

Crypto market outlook for 2026

Year 2025 was volatile, as crypto often is.  Among positive catalysts were favourable regulatory changes in the U.S., rise of Digital Asset Treasuries (DAT), adoption of AI and tokenization of Real-World-Assets (RWA).